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ABSTRACT  
Graphene oxide (GO) possesses excellent mechanical strength, biocompatibility, colloidal 
stability, large surface area and high adsorption capability. It has driven to cancer 
nanotechnology to defeat cancer therapy obstacles, via integration into three-dimensional 
(3D) hydrogel network with biocompatible polymers as nanocomposites carrier, and 
controllable release of anticancer drugs. Specifically, the surface of GO affords π-π stacking 
and hydrophilic interactions with anticancer drugs. Additionally, modification of GO with 
various polymers such as natural and synthetic polymers enhances its biodegradability, drug 
loading, and target delivery. In this review, GO based hydrogels research accomplishments 
are reviewed on the aspects of crosslinking strategies, preparation methods, the model drug, 
polymer conjugation and modification with targeting ligands. Moreover, swelling kinetics, 
drug release profile and biological activity in vivoand in vitro are discussed. The 
biocompatibility of GO based hydrogels is also discussed from the perspective of its nano-bio 
interfaces. Apart from that, the clinical potential of GO based hydrogels and its major 
challenges are addressed in detail. Finally, this review concludes with a summary and 
invigorating future perspectives of GO based hydrogels for anticancer drug delivery. It is 
anticipated that this review can stimulate a new research gateway to facilitate the 
development of anticancer drug delivery by harnessing the unique properties of GO based 
hydrogels, such as large surface area, chemical purity, high loading capacity of drug, chemical 
stability, and the nature of lipophilic for cell membrane penetration. 
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